University of Melbourne leading The Australian Centre for Accelerating Diabetes Innovations (ACADI): $10 million awarded

D.T.R.G lead by Professor David O’NEAL is a major contributor to this centre with 3 projects supporting people with diabetes

We are delighted to announce that University of Melbourne will be leading The Australian Centre for Accelerating Diabetes Innovations with funding of $23.3 million over the next four years, aimed at improving the lives of people living with diabetes.

Established by MTP Confect’s Targeted Transition Research Accelerator (TTRA) Initiative, the ACADI Research Centre has been awarded $10 million over four years from the Australian Government’s Medical Research Future Fund.

Co-contributions from academic and industry partners will allow ACADI to progress 18 research projects addressing diabetic kidney disease, peripheral neuropathy and diabetic foot syndrome, short-term complications of hypoglycemia, hyperglycaemic hyperosmolar syndrome (HHS) and ketoacidosis.

The Australian Centre for Accelerating Diabetes Innovations will be led by Elif Ekinci, with Professor David O’Neal leading or involved with many projects in a great team of collaborators, partners and advisors across the country and abroad

Quote from Prof O’Neal : We are privileged to be part of the ACADI family.

The Centre has provided substantial funding for three studies led by the diabetes technology team at St Vincent’s Hospital Melbourne.

These relate to glucose control in kidney disease, empowering the patient with type 1 diabetes using technology and the evaluation of a novel ketone sensor.

https://medicine.unimelb.edu.au/research/acadi

Share this post

University of Melbourne leading The Australian Centre for Accelerating Diabetes Innovations (ACADI): $10 million awarded

D.T.R.G lead by Professor David O’NEAL is a major contributor to this centre with 3 projects supporting people with diabetes

We are delighted to announce that University of Melbourne will be leading The Australian Centre for Accelerating Diabetes Innovations with funding of $23.3 million over the next four years, aimed at improving the lives of people living with diabetes.

Established by MTP Confect’s Targeted Transition Research Accelerator (TTRA) Initiative, the ACADI Research Centre has been awarded $10 million over four years from the Australian Government’s Medical Research Future Fund.

Co-contributions from academic and industry partners will allow ACADI to progress 18 research projects addressing diabetic kidney disease, peripheral neuropathy and diabetic foot syndrome, short-term complications of hypoglycemia, hyperglycaemic hyperosmolar syndrome (HHS) and ketoacidosis.

The Australian Centre for Accelerating Diabetes Innovations will be led by Elif Ekinci, with Professor David O’Neal leading or involved with many projects in a great team of collaborators, partners and advisors across the country and abroad

Quote from Prof O’Neal : We are privileged to be part of the ACADI family.

The Centre has provided substantial funding for three studies led by the diabetes technology team at St Vincent’s Hospital Melbourne.

 

These relate to glucose control in kidney disease, empowering the patient with type 1 diabetes using technology and the evaluation of a novel ketone sensor.

 

https://medicine.unimelb.edu.au/research/acadi

Share this post